Skip to main content
Article thumbnail
Location of Repository

CCN2/Connective Tissue Growth Factor Is Essential for Pericyte Adhesion and Endothelial Basement Membrane Formation during Angiogenesis

By Faith Hall-Glenn, R. Andrea De Young, Bau-Lin Huang, Ben van Handel, Jennifer J. Hofmann, Tom T. Chen, Aaron Choi, Jessica R. Ong, Paul D. Benya, Hanna Mikkola, M. Luisa Iruela-Arispe and Karen M. Lyons


CCN2/Connective Tissue Growth Factor (CTGF) is a matricellular protein that regulates cell adhesion, migration, and survival. CCN2 is best known for its ability to promote fibrosis by mediating the ability of transforming growth factor β (TGFβ) to induce excess extracellular matrix production. In addition to its role in pathological processes, CCN2 is required for chondrogenesis. CCN2 is also highly expressed during development in endothelial cells, suggesting a role in angiogenesis. The potential role of CCN2 in angiogenesis is unclear, however, as both pro- and anti-angiogenic effects have been reported. Here, through analysis of Ccn2-deficient mice, we show that CCN2 is required for stable association and retention of pericytes by endothelial cells. PDGF signaling and the establishment of the endothelial basement membrane are required for pericytes recruitment and retention. CCN2 induced PDGF-B expression in endothelial cells, and potentiated PDGF-B-mediated Akt signaling in mural (vascular smooth muscle/pericyte) cells. In addition, CCN2 induced the production of endothelial basement membrane components in vitro, and was required for their expression in vivo. Overall, these results highlight CCN2 as an essential mediator of vascular remodeling by regulating endothelial-pericyte interactions. Although most studies of CCN2 function have focused on effects of CCN2 overexpression on the interstitial extracellular matrix, the results presented here show that CCN2 is required for the normal production of vascular basement membranes

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. 5 and 14.5 of gestation.
  2. (2003). A gene expression atlas of the central nervous system based on bacterial artificial chromosomes.
  3. (2006). A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2/CTGF) promotes adhesion and migration of activated pancreatic stellate cells.
  4. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs.
  5. (2004). A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos.
  6. (2005). Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.
  7. (1997). Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.
  8. (2011). Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis.
  9. (2008). Arterial remodeling in vascular disease: a key role for hyaluronan and versican.
  10. (2002). Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor.
  11. (2007). CCN2 (Connective Tissue Growth Factor) is essential for extracellular matrix production and integrin signaling in chondrocytes.
  12. (2004). CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin.
  13. (2006). CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts.
  14. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis.
  15. (1998). Characterization of cell-associated and soluble forms of connective tissue growth CCN2 Is Essential for Angiogenesis In
  16. (2004). Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development.
  17. (2010). Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals.
  18. (2005). Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor.
  19. (2004). Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan.
  20. (2007). Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts.
  21. (2007). Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin.
  22. (2002). Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
  23. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development.
  24. (1999). Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo.
  25. (2008). Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice.
  26. (1991). Connective Tissue Growth Factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.
  27. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.
  28. (2006). CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1.
  29. (2003). CTGF expression during mouse embryonic development.
  30. (2008). CTGF inhibits BMP-7 signaling in diabetic nephropathy.
  31. (2002). CYR61 (CCN1) is essential for placental development and vascular integrity.
  32. (2002). Distribution of PG-M/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration, and neoangiogenesis in vitro.
  33. (1997). ECM-associated signaling molecules: activities, metabolism, and localization during development.
  34. (2005). Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization.
  35. (2009). Endothelial-mural cell signaling in vascular development and angiogenesis.
  36. (2004). Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities.
  37. (2011). Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.
  38. (2002). Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease.
  39. (2009). Fibronectins in vascular morphogenesis.
  40. (1999). Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo.
  41. (1999). Fisp12/Mouse Connective Tissue Growth Factor mediates endothelial cell adhesion and migration through integrin avb3, promotes endothelial cell survival, and induces angiogenesis in vivo.
  42. (2009). Functions and mechanisms of action of CCN matricellular proteins.
  43. (2005). Gene expression of connective tissue growth factor in adult mouse.
  44. (1999). Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days
  45. (2001). Involvement of CTGF, a hypertrophic chondrocyte-specific gene product, in tumor angiogenesis.
  46. (2001). Leask A
  47. Leask A (2011) CCN2 is required for bleomycin-induced skin fibrosis in mice.
  48. (2002). Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
  49. (2005). Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression.
  50. (2003). Molecular regulation of vessel maturation.
  51. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.
  52. (2009). Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation.
  53. (2010). Pericytes are required for blood-brain barrier integrity during embryogenesis.
  54. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche.
  55. (2008). Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.
  56. (2002). Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
  57. (1997). Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth.
  58. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
  59. (2002). Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis.
  60. (2011). Role of laminins in physiological and pathological angiogenesis.
  61. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse.
  62. (2010). Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.
  63. (2007). Specific downregulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
  64. (2010). Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.
  65. (2001). The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts.
  66. (2003). The CCN family: a new stimulus package.
  67. (2010). The first trimester human placenta is a site for terminal maturation of primitive erythroid cells.
  68. (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor.
  69. Trackman PC (2006) CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins.
  70. (2000). Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.